Samarium-153
Sm-153 · Samarium, Z = 62, A = 153
Samarium-153 (Sm-153) carries 1.64e+16 Bq/g, or 4.43e+5 Ci/g: a gigabecquerel is 61.0 ng, no weighable quantity at all. It decays by beta-minus emission with a half-life of 46.284 hours, which leaves 8.08% of today's activity after a week and 6.2e-13% after three months.
At 0.0107 mGy·m²/(GBq·h) the air kerma rate constant is 7.2× less than Cs-137 and 28× less than Co-60, placing it 66 of 96 photon emitters in this dataset.
Shielding barely arises: 0.0673 mm of lead halves the air kerma rate and 0.281 mm takes it to a tenth. Steel does the halving in 0.499 mm. At 1 GBq and a metre the photon dose rate is already under 20 µSv/h with nothing in the way. The tenth-value layer runs 4.2 times the half-value layer, not the 3.32 a single energy would give.
The beta endpoint is 0.807 MeV, mean 0.225 MeV over 15 branches. That endpoint stops in 2.63 mm of acrylic or 1.25 mm of glass. Of the beta energy, 0.18% turns into X-rays in acrylic and 2.32% in lead.
Sm-153 for bone pain palliation
Sm-153 labelled with a phosphonate concentrates in bone that is being remodelled around metastases, where its beta relieves pain in most patients for a few months. It is one of the beta emitters long used for that purpose, alongside Sr-89, with the advantage that its gamma emission lets the distribution be imaged with a gamma camera. It is produced by neutron irradiation of samarium enriched in Sm-152, and a half-life of only a couple of days means each batch is shipped and injected within the week. The unconverted target atoms cannot be removed chemically and stay as carrier, unimportant for a phosphonate given with excess ligand but saturating receptor sites when a targeted molecule is labelled, so mass separation has been tried.
Most of the external dose rate comes from europium X-rays after the decay and most of the rest from one gamma line of modest energy, so lead foil far thinner than a millimetre halves it; the therapeutic beta has its own range figures on the page. Soft photons and the beta both matter in the radionuclide calibrator used to assay each dose: a setting established for a glass vial over-reads the same activity in a plastic syringe, whose wall absorbs less of the beta and whose geometry differs. Patients have been under-treated in series before a syringe-specific correction was applied.
The solution's own radiation breaks down the ligand, so the product is shipped frozen on dry ice and is used within hours of thawing, never refrozen. A treated patient is a weak external source and is often released the same day with advice about excreta. Activity that bone does not take up leaves in the urine within hours, so patients drink beforehand and void often, and an incontinent patient is catheterised to keep urine off clothing and bedding.
The Sm-153 in stored waste falls to background within a few weeks, but neutron capture on the daughter Eu-153 during irradiation leaves a trace of long-lived Eu-154 in the product. Its share grows as the samarium decays, limiting shelf life, and it stays in the skeleton, so the product information asks that it be considered in waste disposal and when a radiation alarm is triggered. The dose-limiting effect of treatment is suppression of the bone marrow, which follows from the deposition of the phosphonate in bone, not from any external exposure.
- IAEA Live Chart of Nuclides (ENSDF decay data)
- European Medicines Agency, Quadramet (samarium-153 lexidronam) EPAR: product information and scientific discussion
- Van de Voorde M. et al., Production of Sm-153 with very high specific activity for targeted radionuclide therapy, Frontiers in Medicine (2021)
- Wisconsin Department of Health Services, Information notice concerning medical events caused by failure to properly perform tests on dose calibrators for beta- and low-energy photon-emitting radionuclides (reissue of US NRC IN 2002-19; Sm-153 in glass vials and plastic syringes)
- US NRC Information Notice 2002-19, Medical misadministrations caused by failure to properly perform tests on dose calibrators for beta- and low-energy photon-emitting radionuclides (Sm-153 unit dosages)
Half-life, specific activity, dose rate and beta energies
| Half-life | 46.284 hours (1.666e+5 s) |
| Decay mode | beta-minus decay |
| Specific activity | 1.64e+16 Bq/g (4.43e+5 Ci/g) |
| Air kerma rate constant Γ (δ = 20 keV) | 0.0107 mGy·m²/(GBq·h) |
| Dose rate, 1 GBq at 1 m | 0.0107 mGy/h |
| Dose rate, 1 Ci at 1 m | 0.397 mGy/h |
| Kerma-weighted mean photon energy | 68.64 keV |
| Beta endpoint / mean | 0.807 MeV / 0.225 MeV |
37 lines above the cutoff, and what each contributes
One further line below the 20 keV cutoff, at 6.60 keV with 10.7% emission probability, is excluded here and from Γ. Probability and dose share.
| Energy (keV) | Emission probability (%) | Share of dose rate (%) |
|---|---|---|
| 41.54 | 30.03632 | 33.46 |
| 103.18 | 29.14 | 30.08 |
| 40.90 | 16.64613 | 18.92 |
| 47.15 | 9.46266 | 8.95 |
| 69.67 | 4.66823 | 3.75 |
| 48.25 | 2.44137 | 2.24 |
| 97.43 | 0.76347 | 0.74 |
| 531.40 | 0.05467 | 0.37 |
| 533.20 | 0.02955 | 0.20 |
| 83.37 | 0.19087 | 0.16 |
| 75.42 | 0.19232 | 0.16 |
| 89.49 | 0.15736 | 0.14 |
| 539.10 | 0.02066 | 0.14 |
| 172.85 | 0.07227 | 0.14 |
Showing the 14 largest contributors of 37 lines above the cutoff; the remainder together carry 0.56% of the dose rate.
0.0673 mm of lead halves this spectrum
Solved numerically across all 37 lines, narrow beam. Why not one representative energy.
| Material | HVL (mm) | TVL (mm) | TVL / HVL |
|---|---|---|---|
| lead | 0.0673 | 0.281 | 4.18 |
| tungsten | 0.0495 | 0.196 | 3.95 |
| iron | 0.499 | 4.52 | 9.04 |
| copper | 0.332 | 3.24 | 9.76 |
| concrete | 9.01 | 36.5 | 4.06 |
| water | 31.2 | 108 | 3.45 |
| aluminum | 7.14 | 30.7 | 4.30 |
A single energy would give 3.32. Spectrum and attenuation ratios.
2.63 mm of acrylic stops the 0.807 MeV endpoint
Katz–Penfold fit to the 0.807 MeV endpoint — a stopping thickness rather than an attenuation length. Why the material matters more than the thickness.
| Absorber | Range for the endpoint (mm) |
|---|---|
| acrylic | 2.63 |
| aluminum | 1.16 |
| water | 3.13 |
| glass | 1.25 |
| Shield material | Fraction of beta energy converted to X-rays |
|---|---|
| acrylic (Z ≈ 6.5) | 0.18% |
| lead (Z = 82) | 2.32% |
Activity over days and weeks
Ten half-lives is 19.3 days — for Sm-153 itself, a storage problem rather than a disposal one, since those ten half-lives already take it below 0.1% of today's activity. The mean life 1/λ is 2.78 days.
| Elapsed | Fraction remaining |
|---|---|
| 1 half-life | 50.0 % |
| 2 half-lives | 25.0 % |
| 5 half-lives | 3.13 % |
| 10 half-lives | 0.0977 % |
| Time to fall to 10 % of today's activity | 6.41 days |
| Time to fall to 1 % | 12.8 days |
| Time to fall to 0.1 % | 19.2 days |
Limits of these dose rates
- 2.63 mm of acrylic for the 0.807 MeV endpoint: a fitted depth of penetration, not a skin dose.
- Air kerma, 1 µGy counted as 1 µSv — not H*(10).
- Model limits and internal dose.
Gamma, beta and decay calculators for Sm-153
- Gamma dose rate and shielding
- Beta dose rate and shielding
- Decay and half-life
- Mass and activity
- Detection limits (MDA / MDC)
Other Samarium nuclides: Sm-147, Sm-151, Sm-153m
Computed from the IAEA Nuclear Data Section — Livechart API (ENSDF) and the NIST X-Ray Mass Attenuation Coefficients. Derivations and citations.